{"result": {"id": "de1af02d-5954-46fe-a068-f37b87d60314", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>GRASSI G<|>PERSON<|>Grassi G is a researcher who co-authored a consensus document on sleep disorders, high blood pressure, and cardiovascular diseases>  \n##  \n(\"entity\"<|>FERRI C<|>PERSON<|>Ferri C is a researcher who contributed to a consensus document on sleep disorders and hypertension>  \n##  \n(\"entity\"<|>AYAPPA IA<|>PERSON<|>Ayappa IA is a researcher involved in a systematic review on obstructive sleep apnea treatment>  \n##  \n(\"entity\"<|>CAPLES SM<|>PERSON<|>Caples SM is a researcher who co-authored a study on obstructive sleep apnea treatment>  \n##  \n(\"entity\"<|>STROHL KP<|>PERSON<|>Strohl KP is a researcher who studied upper airway stimulation for obstructive sleep apnea>  \n##  \n(\"entity\"<|>SOOSE RJ<|>PERSON<|>Soose RJ is a researcher involved in studying upper airway stimulation outcomes>  \n##  \n(\"entity\"<|>GROSSER T<|>PERSON<|>Grosser T is a researcher who investigated the relationship between NSAIDs and hypertension>  \n##  \n(\"entity\"<|>FITZGERALD GA<|>PERSON<|>FitzGerald GA is a researcher who studied the effects of acetaminophen and NSAIDs on hypertension>  \n##  \n(\"entity\"<|>JEONG H<|>PERSON<|>Jeong H is a researcher who studied hypertension prevalence in postmenopausal women>  \n##  \n(\"entity\"<|>YOON JH<|>PERSON<|>Yoon JH is a researcher involved in the Korea National Health and Nutrition Examination Survey>  \n##  \n(\"entity\"<|>ULIANA M<|>PERSON<|>Uliana M is a researcher who contributed to studies on drug-induced hypertension>  \n##  \n(\"entity\"<|>GESI M<|>PERSON<|>Gesi M is a researcher who studied drug-induced hypertension>  \n##  \n(\"entity\"<|>VAISHNAV J<|>PERSON<|>Vaishnav J is a researcher who investigated drug-induced hypertension>  \n##  \n(\"entity\"<|>SPERATI CJ<|>PERSON<|>Sperati CJ is a researcher involved in studies on drug-induced hypertension>  \n##  \n(\"entity\"<|>BURRELLO J<|>PERSON<|>Burrello J is a researcher who studied primary aldosteronism in primary care practice>  \n##  \n(\"entity\"<|>TIZZANI D<|>PERSON<|>Tizzani D is a researcher involved in studies on primary aldosteronism prevalence>  \n##  \n(\"entity\"<|>XU Z<|>PERSON<|>Xu Z is a researcher who studied primary aldosteronism in Chinese patients with hypertension>  \n##  \n(\"entity\"<|>YANG J<|>PERSON<|>Yang J is a researcher who contributed to studies on primary aldosteronism in China>  \n##  \n(\"entity\"<|>HU J<|>PERSON<|>Hu J is a researcher involved in studies on primary aldosteronism detection>  \n##  \n(\"entity\"<|>CAREY RM<|>PERSON<|>Carey RM is a researcher who co-authored clinical practice guidelines for primary aldosteronism>  \n##  \n(\"entity\"<|>MANTERO F<|>PERSON<|>Mantero F is a researcher involved in endocrine society guidelines for primary aldosteronism>  \n##  \n(\"entity\"<|>PILLAI PR<|>PERSON<|>Pillai PR is a researcher who studied cardiovascular risks in primary aldosteronism>  \n##  \n(\"entity\"<|>GRIFFITH M<|>PERSON<|>Griffith M is a researcher who contributed to studies on primary aldosteronism diagnosis>  \n##  \n(\"entity\"<|>SCHWARCZ MD<|>PERSON<|>Schwarcz MD is a researcher involved in primary aldosteronism management studies>  \n##  \n(\"entity\"<|>D’ASCENZO F<|>PERSON<|>D’Ascenzo F is a researcher who conducted systematic reviews on primary aldosteronism>  \n##  \n(\"entity\"<|>MORETTI C<|>PERSON<|>Moretti C is a researcher who contributed to meta-analyses on primary aldosteronism>  \n##  \n(\"entity\"<|>SCONFIEZA E<|>PERSON<|>Sconfienza E is a researcher involved in renal damage studies related to primary aldosteronism>  \n##  \n(\"entity\"<|>ADLER GK<|>PERSON<|>Adler GK is a researcher who studied insulin secretion in primary aldosteronism>  \n##  \n(\"entity\"<|>MURRAY GR<|>PERSON<|>Murray GR is a researcher involved in metabolic studies on primary aldosteronism>  \n##  \n(\"entity\"<|>TURCU AF<|>PERSON<|>Turcu AF is a researcher who contributed to studies on insulin clearance in primary aldosteronism>  \n##  \n(\"entity\"<|>VELEMA M<|>PERSON<|>Velema M is a researcher who compared quality of life in primary aldosteronism treatments>  \n##  \n(\"entity\"<|>DEKKERS T<|>PERSON<|>Dekkers T is a researcher involved in comparative effectiveness studies for primary aldosteronism>  \n##  \n(\"entity\"<|>HERMUS A<|>PERSON<|>Hermus A is a researcher who studied adrenalectomy outcomes in primary aldosteronism>  \n##  \n(\"entity\"<|>MULATERO P<|>PERSON<|>Mulatero P is a researcher who co-authored consensus statements on primary aldosteronism>  \n##  \n(\"entity\"<|>DEINUM J<|>PERSON<|>Deinum J is a researcher involved in position statements on primary aldosteronism>  \n##  \n(\"relationship\"<|>GRASSI G<|>ITALIAN SOCIETY OF HYPERTENSION (SIIA)<|>Grassi G co-authored a document published by the Italian Society of Hypertension<|>7>  \n##  \n(\"relationship\"<|>FERRI C<|>ITALIAN SOCIETY OF HYPERTENSION (SIIA)<|>Ferri C contributed to a consensus document by the Italian Society of Hypertension<|>7>  \n##  \n(\"relationship\"<|>AYAPPA IA<|>AMERICAN ACADEMY OF SLEEP MEDICINE<|>Ayappa IA was involved in a systematic review by the American Academy of Sleep Medicine<|>7>  \n##  \n(\"relationship\"<|>CAPLES SM<|>AMERICAN ACADEMY OF SLEEP MEDICINE<|>Caples SM co-authored a study published by the American Academy of Sleep Medicine<|>7>  \n##  \n(\"relationship\"<|>STROHL KP<|>OBSTRUCTIVE SLEEP APNEA<|>Strohl KP researched upper airway stimulation for obstructive sleep apnea<|>8>  \n##  \n(\"relationship\"<|>SOOSE RJ<|>OBSTRUCTIVE SLEEP APNEA<|>Soose RJ studied outcomes of obstructive sleep apnea treatments<|>8>  \n##  \n(\"relationship\"<|>GROSSER T<|>FITZGERALD GA<|>Grosser T and FitzGerald GA jointly researched NSAIDs and hypertension<|>8>  \n##  \n(\"relationship\"<|>JEONG H<|>KOREA NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (KNHANESV)<|>Jeong H contributed to the KNHANESV study on hypertension<|>7>  \n##  \n(\"relationship\"<|>YOON JH<|>KOREA NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (KNHANESV)<|>Yoon JH was involved in the KNHANESV research<|>7>  \n##  \n(\"relationship\"<|>MULATERO P<|>WORKING GROUP ON ENDOCRINE HYPERTENSION OF THE EUROPEAN SOCIETY OF HYPERTENSION<|>Mulatero P co-authored a consensus statement for the Working Group<|>8>  \n##  \n(\"relationship\"<|>DEINUM J<|>WORKING GROUP ON ENDOCRINE HYPERTENSION OF THE EUROPEAN SOCIETY OF HYPERTENSION<|>Deinum J contributed to the Working Group's position statement<|>8>  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751559104, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 1929, "prompt_tokens": 4082, "total_tokens": 6011, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 4032}, "prompt_cache_hit_tokens": 4032, "prompt_cache_miss_tokens": 50}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 7177.\n[695]  WangM, Wang M, Zhu Q, etal.  Developmentand validation ofa coronaryheartdiseaserisk prediction modelin snorerswith hypertension: a retrospective observed study[J]. Risk Manag HealthcPolicy,2022,15:1999-2009.\n[696]  WangMH, HeizhatiM, LiNF, etal. Developmentandvalida- tion ofaprognosticmodelto predicthigh-risk patientsforcoro- naryheartdiseasein snorerswithuncontrolledhypertension[J].   FrontCardiovascMed,2022,9:777946.\n[697]  DelPintoR, GrassiG, FerriC, etal. Diagnosticand therapeu- ticapproach to sleep disorders, highblood pressure and cardio- vasculardiseases: aconsensusdocumentbytheItalianSocietyof Hypertension (SIIA) [J]. High Blood Press Cardiovasc Prev,  2021,28(2) :85-102.\n[698]  PatilSP, AyappaIA, CaplesSM, etal. Treatmentofadultob- structivesleepapneawithpositiveairwaypressure: anAmerican Academy of Sleep Medicine systematic review, meta-analysis,  andGRADE assessment[J]. J Clin SleepMed,2019,15(2) :301- 334.\n[699]  Woodson BT, StrohlKP, SooseRJ, etal. Upperairwaystimu- lation forobstructive sleep apnea: 5-year outcomes[J]. Otolar- yngolHead Neck Surg,2018,159(1) :194-202.\n[700]  Spence JD, Grosser T, FitzGerald GA.  Acetaminophen,  non- steroidalanti-inflammatorydrugs, and hypertension[J]. Hyper- tension,2022,79(9) :1922-1926.\n[701]  LeeJ, Jeong H, YoonJH, etal. Association between pastoral contraceptiveuse and the prevalence of hypertension in postm-\n\n\n\n　enopausal women:  the fifth  ( 2010     2012)  Korea National Health and Nutrition Examination Survey (KNHANESV) [J].   BMCPublicHealth,2022,22(1) :27.\n[702]  MasiS, UlianaM, GesiM, etal. Drug-induced hypertension:  know theproblem to know how to dealwithit[J]. VasculPhar- macol,2019,115:84-88.\n[703]  FoyMC, VaishnavJ, SperatiCJ.  Drug-inducedhypertension[J]. EndocrinolMetabClin NorthAm,2019,48(4) :859-873.\n[704]  MonticoneS, BurrelloJ, TizzaniD, etal. Prevalenceand clini- calmanifestations of primary aldosteronism encountered in pri- mary carepractice[J]. J Am CollCardiol, 2017, 69(14) : 1811- 1820.\n[705]  XuZ, YangJ, HuJ, etal. Primaryaldosteronism inpatientsin Chinawith recentlydetected hypertension[J]. JAm CollCardi- ol,2020,75(16) :1913-1922.\n[706]  FunderJW , CareyRM, ManteroF, etal. The managementof primary aldosteronism:  case detection,  diagnosis,  and treat- ment: an EndocrineSociety clinicalpractice guideline[J]. JClin EndocrinolMetab,2016,101(5) :1889-1916.\n[707]  PillaiPR, GriffithM, SchwarczMD, etal. Primaryaldosteron- ism: cardiovascularrisk, diagnosis, and management[J]. Cardi- olRev,2020,28(2) :84-91.\n[708]  MonticoneS, D’Ascenzo F, MorettiC, et al.  Cardiovascular eventsand targetorgan damage in primary aldosteronism com- paredwithessentialhypertension: asystematicreview andmeta- analysis[J]. LancetDiabetesEndocrinol,2018,6(1) :41-50.\n[709]  MonticoneS, SconfienzaE, D’AscenzoF, etal. Renaldamage in primaryaldosteronism: asystematicreview andmeta-analysis [J]. J Hypertens,2020,38(1) :3-12.\n[710]  AdlerGK, MurrayGR, Turcu AF, etal. Primary aldosteron- ism decreasesinsulin secretion and increases insulin clearance in humans[J]. Hypertension,2020,75(5) :1251-1259.\n[711]  VelemaM, DekkersT, HermusA, etal. Qualityoflifein pri- mary aldosteronism: a comparative effectiveness study ofadre- nalectomy and medicaltreatment[J]. JClin Endocrinol Metab,  2018,103(1) :16-24.\n[712]  MulateroP, MonticoneS, Deinum J,  etal.  Genetics, prevalence,  screening and confirmation ofprimary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension[J]. J Hypertens,2020,38(10)\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>ITALIAN SOCIETY OF HYPERTENSION (SIIA)<|>ORGANIZATION<|>The Italian Society of Hypertension (SIIA) is a professional organization that published a consensus document on sleep disorders, high blood pressure, and cardiovascular diseases>  \n##  \n(\"entity\"<|>AMERICAN ACADEMY OF SLEEP MEDICINE<|>ORGANIZATION<|>The American Academy of Sleep Medicine conducted a systematic review and meta-analysis on the treatment of adult obstructive sleep apnea with positive airway pressure>  \n##  \n(\"entity\"<|>KOREA NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (KNHANESV)<|>ORGANIZATION<|>The Korea National Health and Nutrition Examination Survey (KNHANESV) is a national survey that studied the association between pastoral contraceptive use and hypertension in postmenopausal women>  \n##  \n(\"entity\"<|>WORKING GROUP ON ENDOCRINE HYPERTENSION OF THE EUROPEAN SOCIETY OF HYPERTENSION<|>ORGANIZATION<|>The Working Group on Endocrine Hypertension of The European Society of Hypertension published a position statement and consensus on primary aldosteronism>  \n##  \n(\"entity\"<|>WANG M<|>PERSON<|>Wang M is a researcher who contributed to studies on coronary heart disease risk prediction in snorers with hypertension>  \n##  \n(\"entity\"<|>WANG MH<|>PERSON<|>Wang MH is a researcher involved in developing a prognostic model for high-risk coronary heart disease patients among snorers with uncontrolled hypertension>  \n##  \n(\"entity\"<|>DEL PINTO R<|>PERSON<|>Del Pinto R is a researcher who co-authored a consensus document on sleep disorders, high blood pressure, and cardiovascular diseases>  \n##  \n(\"entity\"<|>PATIL SP<|>PERSON<|>Patil SP is a researcher involved in a systematic review and meta-analysis on obstructive sleep apnea treatment>  \n##  \n(\"entity\"<|>WOODSON BT<|>PERSON<|>Woodson BT is a researcher who studied upper airway stimulation for obstructive sleep apnea>  \n##  \n(\"entity\"<|>SPENCE JD<|>PERSON<|>Spence JD is a researcher who investigated the relationship between acetaminophen, NSAIDs, and hypertension>  \n##  \n(\"entity\"<|>LEE J<|>PERSON<|>Lee J is a researcher who studied the association between pastoral contraceptive use and hypertension in postmenopausal women>  \n##  \n(\"entity\"<|>MASI S<|>PERSON<|>Masi S is a researcher who contributed to studies on drug-induced hypertension>  \n##  \n(\"entity\"<|>FOY MC<|>PERSON<|>Foy MC is a researcher who studied drug-induced hypertension>  \n##  \n(\"entity\"<|>MONTICONE S<|>PERSON<|>Monticone S is a researcher involved in multiple studies on primary aldosteronism, including its prevalence, clinical manifestations, and cardiovascular risks>  \n##  \n(\"entity\"<|>FUNDER JW<|>PERSON<|>Funder JW is a researcher who contributed to clinical practice guidelines on the management of primary aldosteronism>  \n##  \n(\"entity\"<|>PRIMARY ALDOSTERONISM<|>EVENT<|>Primary aldosteronism is a condition characterized by excessive aldosterone production, leading to hypertension and cardiovascular risks>  \n##  \n(\"entity\"<|>OBSTRUCTIVE SLEEP APNEA<|>EVENT<|>Obstructive sleep apnea is a sleep disorder treated with positive airway pressure, as studied by the American Academy of Sleep Medicine>  \n##  \n(\"relationship\"<|>ITALIAN SOCIETY OF HYPERTENSION (SIIA)<|>DEL PINTO R<|>Del Pinto R co-authored a consensus document published by the Italian Society of Hypertension<|>7>  \n##  \n(\"relationship\"<|>AMERICAN ACADEMY OF SLEEP MEDICINE<|>PATIL SP<|>Patil SP was involved in a systematic review conducted by the American Academy of Sleep Medicine<|>7>  \n##  \n(\"relationship\"<|>WORKING GROUP ON ENDOCRINE HYPERTENSION OF THE EUROPEAN SOCIETY OF HYPERTENSION<|>MONTICONE S<|>Monticone S contributed to a consensus statement published by the Working Group on Endocrine Hypertension<|>8>  \n##  \n(\"relationship\"<|>PRIMARY ALDOSTERONISM<|>MONTICONE S<|>Monticone S conducted multiple studies on primary aldosteronism<|>9>  \n##  \n(\"relationship\"<|>OBSTRUCTIVE SLEEP APNEA<|>AMERICAN ACADEMY OF SLEEP MEDICINE<|>The American Academy of Sleep Medicine studied treatments for obstructive sleep apnea<|>8>  \n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_85c4006f162c5bcf838af58a91d95b11aed08d9f81cfed26cb3968493cc7a0a7_v2"}